Don HautCEO & Director at Carmine Therapeutics, USA
Dr. Haut is CEO of Carmine Therapeutics – a leader in non-viral gene therapy. In a career spanning academic science, consulting, business development, Dr. Haut has held executive leadership roles, and Board of Directors roles in biotech, pharmaceutical, and medical device companies, and has completed transactions exceeding $8 billion and been instrumental in multiple product launches. Originally trained as a molecular biologist before joining McKinsey, he has since held senior business roles at 3M Company, Smith & Nephew, The Medicines Company, Histogenics and AskBio. He earned his PhD in Molecular Biology from the Medical School at the University of Missouri-Columbia and an MBA from Washington University’s Olin School of Business.